Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Pharmacotherapy for Treatment of Cognitive and Neuropsychiatric Symptoms After mTBI.

Rabinowitz AR, Watanabe TK.

J Head Trauma Rehabil. 2020 Jan/Feb;35(1):76-83. doi: 10.1097/HTR.0000000000000537.

PMID:
31834058
2.

Oman coral δ18O seawater record suggests that Western Indian Ocean upwelling uncouples from the Indian Ocean Dipole during the global-warming hiatus.

Watanabe TK, Watanabe T, Yamazaki A, Pfeiffer M, Claereboudt MR.

Sci Rep. 2019 Feb 13;9(1):1887. doi: 10.1038/s41598-018-38429-y.

3.

The Transformation of the Rehabilitation Paradigm Across the Continuum of Care.

Watanabe TK, Esquenazi A, Flanagan S.

PM R. 2018 Sep;10(9 Suppl 2):S264-S271. doi: 10.1016/j.pmrj.2018.08.381. Review.

PMID:
30269811
4.

A Review of Stem Cell Therapy for Acquired Brain Injuries and Neurodegenerative Central Nervous System Diseases.

Watanabe TK.

PM R. 2018 Sep;10(9 Suppl 2):S151-S156. doi: 10.1016/j.pmrj.2018.07.008. Review.

PMID:
30269801
5.

Fully Implantable Peripheral Nerve Stimulation for Hemiplegic Shoulder Pain: A Multi-Site Case Series With Two-Year Follow-Up.

Wilson RD, Bennett ME, Nguyen VQC, Bock WC, O'Dell MW, Watanabe TK, Amundson RH, Hoyen HA, Chae J.

Neuromodulation. 2018 Apr;21(3):290-295. doi: 10.1111/ner.12726. Epub 2017 Nov 22.

6.

Mood Stabilizers for Traumatic Brain Injury-Related Agitation.

Kalra ID, Watanabe TK.

J Head Trauma Rehabil. 2017 Nov/Dec;32(6):E61-E64. doi: 10.1097/HTR.0000000000000359. Review. No abstract available.

PMID:
29095772
7.

Past summer upwelling events in the Gulf of Oman derived from a coral geochemical record.

Watanabe TK, Watanabe T, Yamazaki A, Pfeiffer M, Garbe-Schönberg D, Claereboudt MR.

Sci Rep. 2017 Jul 4;7(1):4568. doi: 10.1038/s41598-017-04865-5.

8.

Natural History of Headache Five Years after Traumatic Brain Injury.

Stacey A, Lucas S, Dikmen S, Temkin N, Bell KR, Brown A, Brunner R, Diaz-Arrastia R, Watanabe TK, Weintraub A, Hoffman JM.

J Neurotrauma. 2017 Apr 15;34(8):1558-1564. doi: 10.1089/neu.2016.4721. Epub 2017 Jan 18.

PMID:
27927072
9.

Risk Factors for Institutionalization After Traumatic Brain Injury Inpatient Rehabilitation.

Eum RS, Brown AW, Watanabe TK, Zasler ND, Goldstein R, Seel RT, Roth EJ, Zafonte RD, Glenn MB.

J Head Trauma Rehabil. 2017 May/Jun;32(3):158-167. doi: 10.1097/HTR.0000000000000246.

PMID:
27455433
10.

Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management Strategies.

Ginsberg DA, Schneider LK, Watanabe TK.

Arch Phys Med Rehabil. 2015 Sep;96(9 Suppl):S341-57.e1. doi: 10.1016/j.apmr.2015.05.016.

PMID:
26318392
11.

Determining the need for pain medications for a patient with a disorder of consciousness.

Schnakers C, Marino MH, Watanabe TK.

PM R. 2015 Mar;7(3):315-21. doi: 10.1016/j.pmrj.2015.02.014. No abstract available.

PMID:
25797615
12.

Predicting institutionalization after traumatic brain injury inpatient rehabilitation.

Eum RS, Seel RT, Goldstein R, Brown AW, Watanabe TK, Zasler ND, Roth EJ, Zafonte RD, Glenn MB.

J Neurotrauma. 2015 Feb 15;32(4):280-6. doi: 10.1089/neu.2014.3351. Epub 2014 Dec 5.

13.

Headache after traumatic brain injury: a national survey of clinical practices and treatment approaches.

Brown AW, Watanabe TK, Hoffman JM, Bell KR, Lucas S, Dikmen S.

PM R. 2015 Jan;7(1):3-8. doi: 10.1016/j.pmrj.2014.06.016. Epub 2014 Jul 11.

PMID:
25019492
14.

The utility of routine screening for deep vein thrombosis upon admission to an inpatient brain injury rehabilitation unit.

Greenwald BD, Park MJ, Levine JM, Watanabe TK.

PM R. 2013 Apr;5(4):340-7. doi: 10.1016/j.pmrj.2013.03.006. No abstract available.

PMID:
23622787
15.

Use of methylphenidate during inpatient rehabilitation after traumatic brain injury.

Walker WC, Bell KR, Watanabe TK.

PM R. 2012 Oct;4(10):778-82. doi: 10.1016/j.pmrj.2012.09.584. No abstract available.

PMID:
23093220
16.

Systematic review of interventions for post-traumatic headache.

Watanabe TK, Bell KR, Walker WC, Schomer K.

PM R. 2012 Feb;4(2):129-40. doi: 10.1016/j.pmrj.2011.06.003. Review.

PMID:
22373462
17.

Natural history of headache after traumatic brain injury.

Hoffman JM, Lucas S, Dikmen S, Braden CA, Brown AW, Brunner R, Diaz-Arrastia R, Walker WC, Watanabe TK, Bell KR.

J Neurotrauma. 2011 Sep;28(9):1719-25. doi: 10.1089/neu.2011.1914. Epub 2011 Aug 29.

18.

Managing sleepiness after traumatic brain injury.

Greenwald B, Lombard LA, Watanabe TK.

PM R. 2011 May;3(5):480-5. doi: 10.1016/j.pmrj.2011.04.010. No abstract available.

PMID:
21570037
19.

Role of oral medications in spasticity management.

Watanabe TK.

PM R. 2009 Sep;1(9):839-41. doi: 10.1016/j.pmrj.2009.07.014. Review.

PMID:
19769918
20.

Protective effect against Parkinson's disease-related insults through the activation of XBP1.

Sado M, Yamasaki Y, Iwanaga T, Onaka Y, Ibuki T, Nishihara S, Mizuguchi H, Momota H, Kishibuchi R, Hashimoto T, Wada D, Kitagawa H, Watanabe TK.

Brain Res. 2009 Feb 27;1257:16-24. doi: 10.1016/j.brainres.2008.11.104. Epub 2008 Dec 16.

PMID:
19135031
21.

Altered emotional behaviors in the diabetes mellitus OLETF type 1 congenic rat.

Watanabe A, Okuno S, Okano M, Jordan S, Aihara K, Watanabe TK, Yamasaki Y, Kitagawa H, Sugawara K, Kato S.

Brain Res. 2007 Oct 31;1178:114-24. Epub 2007 Aug 15.

PMID:
17916333
22.

Mutated G-protein-coupled receptor GPR10 is responsible for the hyperphagia/dyslipidaemia/obesity locus of Dmo1 in the OLETF rat.

Watanabe TK, Suzuki M, Yamasaki Y, Okuno S, Hishigaki H, Ono T, Oga K, Mizoguchi-Miyakita A, Tsuji A, Kanemoto N, Wakitani S, Takagi T, Nakamura Y, Tanigami A.

Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):355-66.

PMID:
15854142
23.

Embryonic stem cells form articular cartilage, not teratomas, in osteochondral defects of rat joints.

Wakitani S, Aoki H, Harada Y, Sonobe M, Morita Y, Mu Y, Tomita N, Nakamura Y, Takeda S, Watanabe TK, Tanigami A.

Cell Transplant. 2004;13(4):331-6.

PMID:
15468674
24.

Integration of the rat recombination and EST maps in the rat genomic sequence and comparative mapping analysis with the mouse genome.

Wilder SP, Bihoreau MT, Argoud K, Watanabe TK, Lathrop M, Gauguier D.

Genome Res. 2004 Apr;14(4):758-65.

25.

A < 1.7 cM interval is responsible for Dmo1 obesity phenotypes in OLETF rats.

Watanabe TK, Okuno S, Yamasaki Y, Ono T, Oga K, Mizoguchi-Miyakita A, Miyao H, Suzuki M, Momota H, Goto Y, Shinomiya H, Hishigaki H, Hayashi I, Asai T, Wakitani S, Takagi T, Nakamura Y, Tanigami A.

Clin Exp Pharmacol Physiol. 2004 Jan-Feb;31(1-2):110-2.

PMID:
14756694
26.

Congenital and acquired brain injury. 5. Outcomes after acquired brain injury.

Watanabe TK, Miller MA, McElligott JM.

Arch Phys Med Rehabil. 2003 Mar;84(3 Suppl 1):S23-7; quiz S28-31. Review.

PMID:
12708555
27.
28.

Congenital and acquired brain injury. 2. Brain injury rehabilitation: medical management.

Burnett DM, Watanabe TK, Greenwald BD.

Arch Phys Med Rehabil. 2003 Mar;84(3 Suppl 1):S8-11. Review.

PMID:
12708552
29.

Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint.

Wakitani S, Takaoka K, Hattori T, Miyazawa N, Iwanaga T, Takeda S, Watanabe TK, Tanigami A.

Rheumatology (Oxford). 2003 Jan;42(1):162-5.

PMID:
12509630
30.

Substitution of Dmo1 with normal alleles results in decreased manifestation of diabetes in OLETF rats.

Okuno S, Kondo M, Yamasaki Y, Miyao H, Ono T, Iwanaga T, Omori K, Okano M, Suzuki M, Momota H, Hishigaki H, Hayashi I, Goto Y, Shinomiya H, Harada Y, Hirashima T, Kanemoto N, Asai T, Wakitani S, Takagi T, Nakamura Y, Tanigami A, Watanabe TK.

Diabetes Obes Metab. 2002 Sep;4(5):309-18.

PMID:
12190994
31.

Analysis of chromosomal aberrations involving chromosome 1q31-->q53 in a DMBA-induced rat fibrosarcoma cell line: amplification and overexpression of Jak2.

Sjöling A, Lindholm H, Samuelson E, Yamasaki Y, Watanabe TK, Tanigami A, Levan G.

Cytogenet Cell Genet. 2001;95(3-4):202-9.

PMID:
12063401
32.

Functional outcome after inpatient rehabilitation in persons with subarachnoid hemorrhage.

O'Dell MW, Watanabe TK, De Roos ST, Kager C.

Arch Phys Med Rehabil. 2002 May;83(5):678-82.

PMID:
11994807
33.

Mouse chromosome 19 and distal rat chromosome 1: a chromosome segment conserved in evolution.

Yamasaki Y, Helou K, Watanabe TK, Sjöling A, Suzuki M, Okuno S, Ono T, Takagi T, Nakamura Y, Stahl F, Tanigami A.

Hereditas. 2001;134(1):23-34.

34.

Effects of Dmo1 on obesity, dyslipidaemia and hyperglycaemia in the Otsuka Long Evans Tokushima Fatty strain.

Okuno S, Watanabe TK, Ono T, Oga K, Mizoguchi-Miyakita A, Yamasaki Y, Goto Y, Shinomiya H, Momota H, Miyao H, Hayashi I, Asai T, Suzuki M, Harada Y, Hishigaki H, Wakitani S, Takagi T, Nakamura Y, Tanigami A.

Genet Res. 2001 Apr;77(2):183-90.

PMID:
11355573
35.

Genetic analysis of pancreatic duct hyperplasia in Otsuka Long-Evans Tokushima Fatty rats: possible association with a region on rat chromosome 14 that includes the disrupted cholecystokinin-A receptor gene.

Kanemoto N, Kondo M, Iwanaga T, Hishigaki H, Ono T, Mizoguchi-Miyakita A, Oga K, Tsuji A, Okuno S, Watanabe TK, Nose M, Tanigami A.

Pathol Int. 2001 Mar;51(3):133-9.

PMID:
11328527
36.

Single-allele correction of the Dmo1 locus in congenic animals substantially attenuates obesity, dyslipidaemia and diabetes phenotypes of the OLETF rat.

Watanabe TK, Okuno S, Ono T, Yamasaki Y, Oga K, Mizoguchi-Miyakita A, Miyao H, Suzuki M, Momota H, Goto Y, Shinomiya H, Hishigaki H, Hayashi I, Asai T, Wakitani S, Takagi T, Nakamura Y, Tanigami A.

Clin Exp Pharmacol Physiol. 2001 Jan-Feb;28(1-2):28-42.

PMID:
11153534
37.

Quantitative trait loci for lipid metabolism in the study of OLETF x (OLETF x Fischer 344) backcross rats.

Yamasaki Y, Watanabe TK, Okuno S, Ono T, Oga K, Mizoguchi-Miyakita A, Goto Y, Shinomiya H, Momota H, Miyao H, Hayashi I, Asai T, Suzuki M, Harada Y, Hishigaki H, Wakitani S, Takagi T, Nakamura Y, Tanigami A.

Clin Exp Pharmacol Physiol. 2000 Nov;27(11):881-6.

PMID:
11071303
38.

A whole-genome radiation hybrid panel and framework map of the rat genome.

McCarthy LC, Bihoreau MT, Kiguwa SL, Browne J, Watanabe TK, Hishigaki H, Tsuji A, Kiel S, Webber C, Davis ME, Knights C, Smith A, Critcher R, Huxtall P, Hudson JR Jr, Ono T, Hayashi H, Takagi T, Nakamura Y, Tanigami A, Goodfellow PN, Lathrop GM, James MR.

Mamm Genome. 2000 Sep;11(9):791-5. No abstract available.

PMID:
10967141
39.
40.

Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study.

Goorman SD, Watanabe TK, Miller EH, Perry C.

Arch Phys Med Rehabil. 2000 Apr;81(4):479-83.

PMID:
10768539
41.

Characterization of newly developed SSLP markers for the rat.

Watanabe TK, Ono T, Okuno S, Mizoguchi-Miyakita A, Yamasaki Y, Kanemoto N, Hishigaki H, Oga K, Takahashi E, Irie Y, Bihoreau MT, James MR, Lathrop GM, Takagi T, Nakamura Y, Tanigami A.

Mamm Genome. 2000 Apr;11(4):300-5.

PMID:
10754106
42.

Further genetic studies on the Katsunuma population of Drosophila melanogaster.

Hatano Y, Inoue Y, Watada M, Akai SM, Watanabe TK, Yamamoto M, Hirai K, Takegawa H, Itoh M.

Genes Genet Syst. 1999 Oct;74(5):219-25.

43.

Genetic determinants of plasma triglyceride levels in (OLETF x BN) x OLETF backcross rats.

Okuno S, Watanabe TK, Ono T, Yamasaki Y, Goto Y, Miyao H, Asai T, Kanemoto N, Oga K, Mizoguchi-Miyakita A, Takagi T, Takahashi E, Nakamura Y, Tanigami A.

Genomics. 1999 Dec 15;62(3):350-5.

PMID:
10644432
44.

Correction and confirmation of the assignment of Cd1d the evolutionarily conserved CD1D class gene to rat chromosome 2q34 and its relationship to human and mouse loci.

Matsuura A, Kinebuchi M, Katabami S, Chen HZ, Yamada K, Yoshida MC, Horie M, Watanabe TK, Kikuchi K, Sato N.

Cytogenet Cell Genet. 1999;86(3-4):323-4. No abstract available.

PMID:
10575233
45.

Molecular cloning, expression, and mapping of a novel human cDNA, GRP17, highly homologous to human gadd45 and murine MyD118.

Suzuki M, Watanabe TK, Fujiwara T, Nakamura Yp6, Takahashi E, Tanigami A.

J Hum Genet. 1999;44(5):300-3.

PMID:
10496071
46.

Genetic dissection of "OLETF," a rat model for non-insulin-dependent diabetes mellitus: quantitative trait locus analysis of (OLETF x BN) x OLETF.

Watanabe TK, Okuno S, Oga K, Mizoguchi-Miyakita A, Tsuji A, Yamasaki Y, Hishigaki H, Kanemoto N, Takagi T, Takahashi E, Irie Y, Nakamura Y, Tanigami A.

Genomics. 1999 Jun 15;58(3):233-9.

PMID:
10373320
47.

A radiation hybrid map of the rat genome containing 5,255 markers.

Watanabe TK, Bihoreau MT, McCarthy LC, Kiguwa SL, Hishigaki H, Tsuji A, Browne J, Yamasaki Y, Mizoguchi-Miyakita A, Oga K, Ono T, Okuno S, Kanemoto N, Takahashi E, Tomita K, Hayashi H, Adachi M, Webber C, Davis M, Kiel S, Knights C, Smith A, Critcher R, Miller J, Thangarajah T, Day PJ, Hudson JR Jr, Irie Y, Takagi T, Nakamura Y, Goodfellow PN, Lathrop GM, Tanigami A, James MR.

Nat Genet. 1999 May;22(1):27-36.

PMID:
10319858
48.

cDNA cloning and characterization of a human proteasomal modulator subunit, p27 (PSMD9).

Watanabe TK, Saito A, Suzuki M, Fujiwara T, Takahashi E, Slaughter CA, DeMartino GN, Hendil KB, Chung CH, Tanahashi N, Tanaka K.

Genomics. 1998 Jun 1;50(2):241-50.

PMID:
9653651
49.

Diagnosis and rehabilitation strategies for patients with hysterical hemiparesis: a report of four cases.

Watanabe TK, O'Dell MW, Togliatti TJ.

Arch Phys Med Rehabil. 1998 Jun;79(6):709-14. Review.

PMID:
9630154
50.

Genetic dissection of "OLETF", a rat model for non-insulin-dependent diabetes mellitus.

Kanemoto N, Hishigaki H, Miyakita A, Oga K, Okuno S, Tsuji A, Takagi T, Takahashi E, Nakamura Y, Watanabe TK.

Mamm Genome. 1998 Jun;9(6):419-25.

PMID:
9585427

Supplemental Content

Loading ...
Support Center